NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

And their disclosures:

And the rottenness continues.

David A Readon:

... is an advisor to Agios, AnHeart Therapeutics, Avita Biomedical, Blue Rock Therapeutics, Bristol Myers Squibb, Boston Biomedical, CureVac, Del Mar Pharma, DNAtrix, Hoffman-LaRoche, Imvax, Janssen, Kiyatec, Medicenna Therapeutics, Neuvogen, Novartis, Novocure, Pyramid, Sumitomo Dainippon Pharma, Vivacitas Oncology and Y-mabs Therapeutics.

E Antonio Chiocca

... is an advisor to Amacathera, Bionaut Labs, Genenta, Insightec, DNAtrix, Seneca Therapeutics and Theravir; he has equity options in Bionaut Laboratories, DNAtrix, Immunomic Therapeutics, Seneca Therapeutics and Ternalys Therapeutics; he is co-founder and on the board of directors of Ternalys Therapeutics

.. is a founder, board member of and holds equity in Candel Therapeutics.

“GBM has an aggressive effect in part because of a milieu of immunosuppressive factors surrounding the tumor, which enable the tumor’s growth by preventing the immune system from entering and attacking it,” said E. Antonio Chiocca, MD, PhD, chair of the BWH Department of Neurosurgery.


Patents related to oHSV and CAN-3110 are under the possession of Brigham and Women’s Hospital with E Antonio Chiocca. named as co-inventor.

https://www.genengnews.com/topics/cancer/oncolytic-virus-therapy-shows-promise-against-glioblastoma-in-first-human-trial/